威尔士全科诊所口服抗凝药处方选择差异:Dirichlet回归与链接数据分析
本研究链接2019年威尔士417家全科诊所社区调配口服抗凝药(OAC)的限定日剂量数据与疾病登记、人口学及医患数量数据,用Dirichlet回归分析各OAC相对使用比例与诊所及地区特征的关联。结果显示华法林、阿哌沙班、利伐沙班、达比加群和依度沙班相对处方均值分别为37%、32%、23%、3%和6%,处方模式与所属卫生局及最近主要医院显著相关,提示非临床因素可能影响处方决策。
要点
- 2019年威尔士417家全科诊所OAC相对处方均值:华法林37%、阿哌沙班32%、利伐沙班23%、达比加群3%、依度沙班6%。
- 各OAC相对处方比例在诊所间变异大,如华法林范围6%-64%、阿哌沙班2%-65%。
- 处方模式与诊所所属卫生局及最近主要医院相关,提示非患者临床特征因素影响决策。
核心结论
- OAC处方存在系统性变异,按卫生局和最近医院分层,提示患者临床特征和偏好之外的因素可能影响处方决策。
研究设计与样本
- 研究链接2019年威尔士社区调配全部OAC的限定日剂量数据至全科诊所层面,并与疾病登记、患者人口学数据及医患数量链接。
- 采用Dirichlet回归分析每种OAC相对全部OAC处方比例与诊所及地区特征的关联,覆盖417家全科诊所。
主要发现
- 417家全科诊所OAC相对处方均值(范围):华法林37%(6%-64%)、阿哌沙班32%(2%-65%)、利伐沙班23%(0%-66%)、达比加群3%(0%-23%)、依度沙班6%(0%-59%)。
- 统计建模提供强证据表明处方模式与全科诊所所属卫生局及最近主要医院相关。
- 与零模型相比,纳入卫生局的模型使Akaike信息准则下降15%,加入最近主要医院后下降20%,进一步纳入其他协变量后下降27%。
临床怎么用
- 临床药学智能体可关注本地区OAC处方模式与卫生局及最近医院的关联,识别潜在不适宜处方变异。
- 在审核OAC选择时,除患者临床特征和偏好外,应留意机构或地区层面的非临床因素对处方决策的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: There has been sustained growth in the prescribing of direct oral anticoagulants (OACs) in primary care in the UK. Given the different indications, properties and prices of OACs, variation between prescribers is expected; however, a high level of variation may be evidence of inappropriate or suboptimal prescribing. This study examined the variation in the relative use of OACs in primary care in Wales. METHODS: Data on total defined daily doses of all community-dispensed OACs in 2019 were linked at the GP practice level with disease registers, patient demographic data and GP and patient numbers. The relative use of each OAC, as a fraction of all OACs prescribed, was analysed using Dirichlet regression to quantify the association between prescribing patterns and practice and area-level characteristics. RESULTS: Across 417 GP practices, the mean (range) in the relative prescribing of warfarin was 37% (6%-64%), apixaban was 32% (2%-65%), rivaroxaban 23% (0%-66%), dabigatran 3% (0%-23%) and edoxaban 6% (0%-59%). Statistical modelling provided strong evidence that prescribing patterns are associated with a GP practice's health board and also their nearest major hospital. Compared to the null model, a model including health board resulted in a 15% fall in Akaike information criterion, increasing to 20% with the addition of nearest major hospital and 27% including further covariates. CONCLUSION: Systematic variation in OAC prescribing, by health board and based on nearest hospital, indicates that factors other than patient clinical characteristics and preferences may be influencing prescribing decisions.
引用
- Hill-McManus D, Hughes DA. Choice of oral anticoagulant prescribed by general practices in Wales: Application of Dirichlet regression and linked data. Br J Clin Pharmacol. 2022. PMID: 34913178. doi:10.1111/bcp.15183
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。